Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04431947 · ClinicalTrials.gov registry record

Impact of Hybrid Closed-Loop Systems on Sleep and Psychosocial Outcomes in Youth With T1D and Their Parents

A clinical trial of Type 1 Diabetes, sponsored by University of Colorado, Denver.

Completed
Registry status
46
Enrollment target
1
Study location

NCT04431947: Completed study of Type 1 Diabetes, sponsored by University of Colorado, Denver.

NCT04431947 is a study of Type 1 Diabetes that has completed, run by University of Colorado, Denver. The registered enrollment target is 46 participants, below the 767-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04431947, a study of Type 1 Diabetes, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
46 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the impact of the hybrid closed-loop insulin delivery systems on sleep in youth with type 1 diabetes and their parents. Activity watches, surveys and device downloads are used to evaluate sleep in these participants.

Primary Outcome

Change in duration of sleep before and after starting the advanced hybrid closed-loop system using surveys and activity watches

Conditions Studied

Study Locations (1)

Colorado

  • University of Colorado, Barbara Davis Center - Aurora

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2020-03-13
Est. Completion 2022-04-01
University of Colorado, Denver

1,283 total trials

What the finished NCT04431947 record still lists

NCT04431947 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 767-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 0 interventions.

NCT04431947 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT04431947 about?

NCT04431947 is a clinical study titled "Impact of Hybrid Closed-Loop Systems on Sleep and Psychosocial Outcomes in Youth With T1D and Their Parents". This study evaluates the impact of the hybrid closed-loop insulin delivery systems on sleep in youth with type 1 diabetes and their parents. Activity watches, surveys and device downloads are used to evaluate sleep in these participants.

What is the current status of trial NCT04431947?

This trial is currently completed. The enrollment target is 46 participants. The study started on 2020-03-13. Estimated completion is 2022-04-01.

What conditions does trial NCT04431947 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

Who is sponsoring clinical trial NCT04431947?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04431947 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04431947's enrollment target sits among peer trials

46 95th of 198 higher than 103 of 198 other Type 1 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04431947, the US trial registry maintained by the National Library of Medicine. NCT04431947 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.